Skip to main content

Advertisement

Log in

Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

It has been shown that over-expression of Special AT-rich binding protein 1 (SATB1) in breast cancer predicts a poor prognosis. This study was aimed at investigating the effects of silencing SATB1 on mesenchymal derived human osteosarcoma U2OS cells and the underlying mechanisms. The expressions of SATB1 and the related genes in the cells were detected by qRT-PCR and/or Western Blotting. SATB1 silencing was achieved by stable transfection with the vectors expressing small hairpin RNA versus SATB1. Cell proliferation was detected in a microplate reader with Cell Counting Kit-8 and the cell cycle was analyzed by flow cytometry using a cell cycle detection kit. The study found that SATB1 was particularly over-expressed in human osteosarcoma U2OS. Silencing SATB1 inhibited the proliferation of U2OS. It was found that inhibition of cell proliferation resulted from cell cycle arrest due to down-regulated expression of CFGF and JunB. The over-expression of SATB1 is responsible for abnormal proliferation of mesenchymal derived human Osteosatcoma U2OS cells, indicating that silencing SATB1 expression in the cells might be developed as an efficient osteosarcoma therapy. CTGF and JunB were involved in SATB1-mediated proliferation of U2OS cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T (1992) A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70:631–645

    Article  PubMed  CAS  Google Scholar 

  2. Tattermusch A, Brockdorff N (2011) A scaffold for X chromosome inactivation. Hum Genet 130:247–253

    Article  PubMed  CAS  Google Scholar 

  3. Yamaguchi H, Tateno M, Yamasaki K (2006) Solution structure and DNA-binding mode of the matrix attachment region-binding domain of the transcription factor SATB1 that regulates the T-cell maturation. J Biol Chem 281:5319–5327

    Article  PubMed  CAS  Google Scholar 

  4. Seo J, Lozano MM, Dudley JP (2005) Nuclear matrix binding regulates SATB1-mediated transcriptional repression. J Biol Chem 280:24600–24609

    Article  PubMed  CAS  Google Scholar 

  5. Shannon MF (2003) A nuclear address with influence. Nat Genet 34:4–6

    Article  PubMed  CAS  Google Scholar 

  6. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34:42–51

    Article  PubMed  CAS  Google Scholar 

  7. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452:187–193

    Article  PubMed  CAS  Google Scholar 

  8. Zheng J (2008) Is SATB1 a master regulator in breast cancer growth and metastasis? Womens Health (Lond Engl) 4:329–332

    Article  CAS  Google Scholar 

  9. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu XP, Xu ZD (2010) Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 101:80–86

    Article  PubMed  CAS  Google Scholar 

  10. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, Liu K, Wu K, Tong Q (2010) Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 118:855–863

    Article  PubMed  CAS  Google Scholar 

  11. Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y, Furue M (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 64:39–44

    Article  PubMed  CAS  Google Scholar 

  12. Siclari VA, Qin L (2010) Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res 5:78–87

    Article  PubMed  Google Scholar 

  13. Mohseny AB, Machado I, Cai Y, Schaefer KL, Serra M, Hogendoorn PC, Llombart-Bosch A, Cleton-Jansen AM (2011) Functional characterization of osteosarcoma cell lines provides representative models to study the human disease. Lab Invest 91:1195–1205

    Article  PubMed  Google Scholar 

  14. Raile K, Hoflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W (1994) Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. J Cell Physiol 159:531–541

    Article  PubMed  CAS  Google Scholar 

  15. Heldin CH, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B (1986) A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319:511–514

    Article  PubMed  CAS  Google Scholar 

  16. Wang Y, Wei Y, Zhang H, Shi Y, Li Y, Li R (2012) Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase. Med Oncol 29:1328–1334

    Article  PubMed  Google Scholar 

  17. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, Wang R, Zhan L, Li Y, Zhou ZG, Sun XF (2011) Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 27:143–150

    Article  PubMed  Google Scholar 

  18. Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P, Tian D (2012) Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 32(7):1064–1078

    Article  PubMed  CAS  Google Scholar 

  19. Bradham DM, Igarashi A, Potter RL, Grotendorst GR (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285–1294

    Article  PubMed  CAS  Google Scholar 

  20. Maeda A, Nishida T, Aoyama E, Kubota S, Lyons KM, Kuboki T, Takigawa M (2009) CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145:207–216

    Article  PubMed  CAS  Google Scholar 

  21. Fujisawa T, Hattori T, Ono M, Uehara J, Kubota S, Kuboki T, Takigawa M (2008) CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes. Osteoarthr Cartil 16:787–795

    Article  PubMed  CAS  Google Scholar 

  22. Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A, Takigawa M (2006) CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett 580:1376–1382

    Article  PubMed  CAS  Google Scholar 

  23. Jiang CG, Lv L, Liu FR, Wang ZN, Liu FN, Li YS, Wang CY, Zhang HY, Sun Z, Xu HM (2011) Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination. Mol Cancer 10:122

    Article  PubMed  CAS  Google Scholar 

  24. Shaulian E (2010) AP-1–The Jun proteins: oncogenes or tumor suppressors in disguise? Cell Signal 22:894–899

    Article  PubMed  CAS  Google Scholar 

  25. Piechaczyk M, Farras R (2008) Regulation and function of JunB in cell proliferation. Biochem Soc Trans 36:864–867

    Article  PubMed  CAS  Google Scholar 

  26. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136

    Article  PubMed  CAS  Google Scholar 

  27. Johnson KJ, Hensley JB, Kelso MD, Wallace DG, Gaido KW (2007) Mapping gene expression changes in the fetal rat testis following acute dibutyl phthalate exposure defines a complex temporal cascade of responding cell types. Biol Reprod 77:978–989

    Article  PubMed  CAS  Google Scholar 

  28. Wang T, Hao L, Feng Y, Wang G, Qin D, Gu G (2011) Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase. Oncol Res 19:193–201

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by the Platform Fund for The Key Laboratory of Pathobiology, Ministry of Education, Jilin University (No. 450060481302) and Jilin University Initiation Fund (No. 450091105188) for “The Tang Aoqing Distinguished Professor.” We would like to express our great appreciation to Dr. Xuejin Su, for his excellent technical assistance and to Professor F. William Orr from the University of Manitoba in Canada for his great help in revising the manuscript.

Conflict of interest

The authors declare that they have no conflicting or competing interests.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zonggui Wang or Ronggui Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, H., Qu, S., Li, S. et al. Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells. Mol Cell Biochem 378, 39–45 (2013). https://doi.org/10.1007/s11010-013-1591-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-013-1591-0

Keywords

Navigation